Charter Medical

Pre-clinical

Winston-Salem, United StatesFounded 1989chartermedical.com

Charter Medical is a mission-driven, privately-held company singularly focused on evolving single-use processing to make revolutionary therapies more accessible. As part of the Solesis family of companies, it operates an FDA-registered, 16,000 sq ft cleanroom facility in Winston-Salem, NC, and offers deep customization capabilities. The company's product portfolio spans critical areas including cryogenic storage, cell expansion, fluid transfer, and blood component processing, serving leading innovators in biopharma and healthcare.

Founded

1989

AI Company Overview

Technology Platform

A design and manufacturing platform for custom, polymer-based single-use systems for bioprocessing, specializing in cryopreservation, cell expansion, and sterile fluid management applications.

Opportunities

The explosive growth of cell and gene therapies creates massive demand for specialized, scalable single-use solutions.

Charter Medical's deep customization capabilities and focus on this niche position it to form strategic partnerships with leading CGT innovators.

Further integration with Solesis's biomaterials R&D offers a path to proprietary, differentiated products.

Risk Factors

Intense competition from larger, well-capitalized single-use suppliers threatens market share and margins.

The company's fortunes are also tied to the clinical and commercial success of the advanced therapy sector, which faces significant scientific, manufacturing, and reimbursement challenges.

Competitive Landscape

Charter Medical competes with giants like Thermo Fisher (Cytiva), Sartorius, and Merck Millipore, as well as specialized players like Meissner. Its differentiation lies in deep client collaboration for custom solutions, agility, and specialized expertise in cell therapy and blood management, supported by its position within the Solesis biomaterials innovation group.